Natural killer (NK) cells have an important role in the control of viral infections, recognizing virally infected cells through a variety of activating and inhibitory receptors [1] [2] [3] . Epidemiological and functional studies have recently suggested that NK cells can also contribute to the control of HIV-1 infection through recognition of virally infected cells by both activating and inhibitory killer immunoglobulin-like receptors (KIRs) [4] [5] [6] [7] . However, it remains unknown whether NK cells can directly mediate antiviral immune pressure in vivo in humans. Here we describe KIR-associated amino-acid polymorphisms in the HIV-1 sequence of chronically infected individuals, on a population level. We show that these KIR-associated HIV-1 sequence polymorphisms can enhance the binding of inhibitory KIRs to HIV-1-infected CD4 1 T cells, and reduce the antiviral activity of KIR-positive NK cells. These data demonstrate that KIR-positive NK cells can place immunological pressure on HIV-1, and that the virus can evade such NK-cellmediated immune pressure by selecting for sequence polymorphisms, as was previously described for virus-specific T cells and neutralizing antibodies 8 . NK cells might therefore have a previously underappreciated role in contributing to viral evolution.
We hypothesized that HIV-1 can evade recognition by NK cells through the selection of sequence polymorphisms in regions targeted by KIRs, and that KIR-associated polymorphisms in the HIV-1 sequence can be identified on a population level. To test this hypothesis, we examined the relationship between KIR genotypes and HIV-1 polymorphisms in a cohort of 91 untreated, chronically HIV-1-infected individuals ( Supplementary Table 1 ), in whom full-length HIV-1 sequences were determined and HLA-class-I-associated polymorphisms were previously described 9 . We used a decision-tree approach that corrects for phylogenetic structure among the sequences and allows for a multivariate analysis to identify KIR-associated sequence polymorphisms 10 . This analysis led to the identification of 22 positions in the HIV-1 genome at which amino-acid polymorphisms were significantly associated with the presence of a specific KIR gene ( Table 1 and Supplementary Fig. 1 ). Taken together, these data show that HIV-1 can adapt to host KIR genotypes on a population level.
To assess the consequences of these KIR-associated amino-acid polymorphisms for NK-cell-mediated recognition of cells infected with HIV-1, we initially evaluated polymorphisms in a region of HIV-1 that encodes an overlapping segment that spans the carboxy-terminal end of Vpu and the amino-terminal end of Env (polymorphisms 15-18 in Table 1 and Supplementary Fig. 1 ). We selected this region because these polymorphisms were present in both reading frames at significantly higher frequencies in individuals that possessed at least one copy of the KIR2DL2 gene than in individuals that did not ( Table 2 and  Supplementary Tables 2 and 3 ). In amino-acid positions 71 and 74 of Vpu, HIV-1 sequences derived from KIR2DL2-positive individuals encoded a methionine in position Vpu(71) and a histidine in position Vpu(74) in more than 70% of cases. Because of the overlapping Vpu/ Env coding region, these positions of Vpu corresponded to a tryptophan in position Env (17) and a methionine in position Env (20) , respectively. The Vpu(71M/74H) (Env(17W/20M)) sequence was significantly less frequent in HIV-1-infected individuals that did not encode KIR2DL2 (P , 0.0001). Furthermore, the presence of the Vpu(71M) polymorphism was in strong linkage disequilibrium with the Vpu(74H) polymorphism (P 5 3.17 212 ). Taken together, these data demonstrate a significant enrichment of HIV-1 viruses containing the Vpu(71M/74H) (Env(17W/20M)) polymorphism in individuals encoding KIR2DL2.
To determine the functional consequences of these KIR2DL2-associated polymorphisms in Vpu and Env, we constructed HIV-1 viral variants using the backbone of the HIV-1 NL4-3 strain 11, 12 . These variants encoded either the Vpu(71M/74H) (Env(17W/20M)) sequence that was seen in KIR2DL2 1 individuals (referred to as Vpu-Env V/V , with 'V' standing for variant), or the Vpu(71R/74L) (Env(17G/20L)) sequence that was most commonly seen in KIR2DL2 2 subjects (referred to as Vpu-Env WT/WT ). No significant differences were observed in the ability of the viral variants to replicate in primary CD4 1 T cells in vitro ( Supplementary Fig. 2a ). We subsequently assessed whether the different viral variants had any impact on NKcell recognition and/or antiviral activity. Primary CD4 1 T cells were infected with viruses containing either the Vpu-Env V/V or the Vpu-Env WT/WT sequence, and then placed in co-culture with autologous NK cells derived from KIR2DL2 1 or KIR2DL2 2 HIV-1-negative individuals ( Fig. 1 ). Both viruses replicated well in the presence of KIR2DL2 2 NK cells, with less than half a log inhibition of viral replication in the presence of NK cells compared to replication in CD4 1 T cells alone ( Fig. 1a, b ). In contrast, the Vpu-Env WT/WT virus was markedly inhibited by NK cells derived from KIR2DL2 1 , but not KIR2DL2 2 , subjects ( Fig. 1b) . Thus, the Vpu-Env V/V virus, which contains polymorphisms that were strongly associated with the presence of KIR2DL2 on the population level, was not inhibited by KIR2DL2 1 NK cells in vitro, whereas the 'wild-type' variant that was rarely observed in KIR2DL2 1 individuals was strongly inhibited by KIR2DL2 1 NK cells, consistent with the selection of Vpu-Env V/V viruses in KIR2DL2 1 individuals. To elucidate further the mechanism by which KIR2DL2 1 NK cells inhibit replication of Vpu-Env WT/WT viruses, we monitored the induction of CD107a expression on NK cells in vitro after stimulation with autologous CD4 1 T cells infected with either the Vpu-Env WT/WT inhibition of HIV replication by NK cells in vitro. a, The Vpu-Env WT/WT virus was inhibited more robustly than the Vpu-Env V/V virus by NK cells derived from a KIR2DL2 1 individual (grey lines). NK cells derived from a KIR2DL2 2 individual (black lines) did not inhibit either virus. b, The Vpu-Env WT/WT virus (dark grey bars) was inhibited significantly more strongly than the Vpu-Env V/V virus (black bars) by NK cells derived from individuals that expressed KIR2DL2 (n 5 6). NK cells derived from individuals that did not express KIR2DL2 (white bars, n 5 6) did not significantly inhibit either virus. *, P , 0.05; **, P , 0.005; 1, KIR2DL2-positive; 2, KIR2DL2-negative. All results are given as mean and s.e.m.
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or the Vpu-Env V/V virus ( Fig. 2a-c) . Consistent with the viral inhibition data, CD158b 1 NK cells from KIR2DL2 1 individuals were strongly activated by CD4 1 T cells infected with the Vpu-Env WT/WT virus, but not by CD4 1 T cells infected with the Vpu-Env V/V virus ( Fig. 2a-c) . These data are consistent with a model in which the inhibitory NK-cell receptor KIR2DL2 does not bind to cells infected with HIV-1 strains containing the Vpu-Env WT/WT sequence, but can bind to cells infected with HIV-1 Vpu-Env V/V , providing a strong inhibitory signal to KIR2DL2 1 NK cells and thereby protecting cells infected with Vpu-Env V/V viruses from lysis by NK cells.
KIR2DL2 segregates with KIR2DL3, as an allele of the same locus 13 , and is in strong linkage disequilibrium with KIR2DS2 (Wn, weighted normalized statistic for linkage disequilibrium 5 0.976, P , 0.001), therefore most individuals in our cohort expressed both these KIRs. However, the three individuals in our cohort who expressed KIR2DL2 in the absence of KIR2DS2 also encoded the Vpu(71M) polymorphism, indicating that KIR2DL2, not KIR2DS2, is responsible for the association with this polymorphism. To test whether KIR2DL2 was directly involved in the recognition of the viral variants, a KIR2DL2-IgG fusion construct was used to assess whether the Vpu-Env V/V polymorphism modulated the interaction of KIR2DL2 with HIV-1-infected CD4 1 T cells. The KIR2DL2 fusion construct bound robustly to all uninfected CD4 1 T cells, and also bound to CD4 1 T cells infected with the HIV-1 Vpu-Env V/V variant significantly better than to CD4 1 T cells from the same donor infected with the Vpu-Env WT/WT variant ( Fig. 2d-f ). In contrast, the binding of a KIR2DL3 fusion construct to HIV-1-infected CD4 1 T cells was not significantly affected by the KIR2DL2-associated polymorphism ( Fig. 2e, f) . HLA-C group 1 and group 2 molecules serve as the ligands for the inhibitory receptor KIR2DL2, which has been shown to bind with greater affinity to HLA-C group 1 than group 2 (ref. 13) . Staining with the KIR2DL2 fusion construct was consistent with these results, because it bound most strongly to cells from individuals homozygous for HLA-C group 1 ( Supplementary Fig. 3 ). Consistent with these binding data, the Vpu-Env V/V polymorphisms were significantly enriched in KIR2DL2 1 individuals homozygous for HLA-C group 1 (P 5 0.008 for Vpu(71M) and P 5 0.01 for Vpu(74H)). Taken together, these data indicate that the Vpu-Env V/V polymorphism enhances the ability of the inhibitory receptor KIR2DL2 to bind to HIV-1-infected cells, in particular those expressing the ligands with highest affinity for KIR2DL2.
In addition to the Vpu(71M/74H) polymorphism, two additional amino-acid polymorphisms (Gag(138L/I) and Nef(9S/K)) were associated with the presence of the KIR2DL2 gene in the study population ( Table 1 , polymorphisms 2 and 22). We next determined whether these KIR2DL2-associated polymorphisms were also associated with differential recognition of HIV-1-infected cells by KIR2DL2 1 NK cells. Viruses containing the polymorphisms replicated similarly in CD4 1 T cells ( Supplementary Fig. 2b ). As observed for the Vpu and Env variants, viruses containing the amino acids that were rarely observed in KIR2DL2 1 individuals (Gag WT and Nef WT , Table 2 and Supplementary Tables 4 and 5) were inhibited more strongly by NK cells derived from KIR2DL2 1 individuals than were viruses containing the variants selected in KIR2DL2 1 subjects (Fig. 3a, c) . Furthermore, KIR2DL2 1 NK cells degranulated more robustly in response to CD4 1 T cells infected with the Gag WT and Nef WT viruses (Fig. 3b, d) , and KIR2DL2-IgG fusion constructs bound significantly less to CD4 1 T cells infected with the Gag WT and Nef WT viruses than to cells infected with Gag V and Nef V viruses (Fig. 4a-c) . Taken together, these data demonstrate that HIV-1 may evolve in KIR2DL2 1 individuals to enrich particular amino-acid polymorphisms, in an effort to escape recognition by KIR2DL2 1 NK cells.
Increasing amounts of evidence indicate that NK cells have an important role in the control of HIV-1 infection 4-6 . Here we report several amino-acid polymorphisms within the HIV-1 clade B sequence that are significantly associated with the expression of specific KIR genes on the population level. We demonstrate in functional studies that these 'KIR footprints' can modulate the interaction of KIR 1 NK cells with HIV-1-infected CD4 1 T cells. The selection of particular 
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amino-acid residues that result in enhanced binding of inhibitory KIRs to infected cells represents a novel approach by which HIV-1 can evade NK-cell-mediated immunity. The molecular mechanisms and precise receptor-ligand interactions involved in this evasion of NK-cell recognition require further investigation. Previous in vitro studies have demonstrated that sequence variations in HLA-class-I-presented epitopes [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] and small changes in the peptide repertoire presented on HLA class I molecules 24 can both modulate the binding of KIR, providing a potential mechanism for virus-sequence-dependent recognition of infected cells by NK cells. The KIR2DL2-associated sequence polymorphisms studied here had no impact on KIR2DL2 binding to transporter associated with antigen processing (TAP)deficient T2 cells expressing HLA-Cw*0102 ( Supplementary Fig. 4 ), despite some degree of HLA-Cw*0102 stabilization. However, several different HLA-C group 1 molecules might present epitopes in these regions of HIV-1, resulting in differential recognition by KIR2DL2. Additionally, other mechanisms besides the modulation of KIR binding to HLA class I might account for the observed reduction in recognition of variant-virus-infected cells by KIR2DL2 1 NK cells. KIR-associated sequence polymorphisms in HIV-1 proteins might directly modulate the ability of these proteins to be processed and presented 25 , might subtly alter hydrostatic interactions with KIR, or might change the profile of NK-cell receptor ligands expressed on infected cells, as has been described for HIV-1 Nef, Vpu and Vpr 26, 27 . Protective effects of specific KIRs or combinations of KIR and HLA class I have been described for many infectious diseases, including HIV, hepatitis C virus and human papilloma virus. Although KIR2DL2 has not been identified as a protective KIR gene in any of these viral infections, homozygosity of its allotypic counterpart, KIR2DL3, has been associated with the resolution of hepatitis C infection when KIR2DL3 is co-expressed with its ligand, HLA-C group 1 (ref. 28 ). This protective KIR2DL3/HLA-C group 1 combination provides a weaker inhibitory signal, resulting in weaker inhibition of NK cells 28 . Here we describe a mechanism by which HIV-1 selects for sequence polymorphisms in KIR2DL2 1 individuals that lead to an enhanced binding of this inhibitory KIR to infected cells, resulting in the inhibition of NK-cell function and thereby enabling HIV-1 to escape the potential protective role of this KIR. Overall, the data from different viral infections are consistent with a model in which enhanced NK-cell activity can contribute to the control of viral replication, and indicate that viruses can evade this NK-cell-mediated immune pressure by selecting for variants that modulate the recognition of infected cells by KIR.
METHODS SUMMARY
Viral sequencing. Genomic DNA was extracted from samples of peripheral blood mononuclear cells and nested PCR protocols were used to amplify HIV-1 genomes 9 . Phylogenetic analysis of KIR-associated sequence polymorphisms. A decisiontree approach 10 , followed by adjustment for multiple comparisons, was used to identify KIR-associated sequence polymorphisms. Construction of viruses containing sequence polymorphisms. Mutations of interest were inserted into the HIV-1 NL4-3 backbone using the GeneTailor site-directed mutagenesis system 11, 12 . Viral inhibition assay. Viral inhibition assays were performed after infecting CD4 1 T cells with viral constructs, as indicated. The level of viral inhibition was Percentage degranulation a, c, NK cells from KIR2DL2 1 individuals (n 5 5) inhibited the replication of the Nef-WT virus and the Gag-WT virus significantly better than they inhibited replication of the Nef-V and Gag-V viruses. b, d, NK cells derived from KIR2DL2 1 individuals (n 5 5) were activated significantly more by cells infected with the Nef-WT and Gag-WT viruses than by cells infected with Nef-V and Gag-V viruses. However, NK cells derived from KIR2DL2 2 individuals (n 5 3) did not inhibit viral replication or degranulate in response to cells infected with either of the wild-type or variant viruses. *, P , 0.05. All results are given as mean and s.e.m. 
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then calculated as the difference between viral production (p24 Gag) in wells containing autologous NK cells and production in wells containing CD4 1 T cells alone 6 . NK-cell degranulation assay. Degranulation of KIR2DL2 1 NK cells was examined by flow cytometry after co-culture of NK cells with autologous CD4 1 T cells infected with the viral construct indicated, in the presence of Golgi-stop and anti-CD107a-PECy5 for 6 h (ref. 29) . NK cells were stained with anti-CD3, anti-CD56, anti-CD16 and anti-CD158b (KIR2DL2/2DL3/2DS2) antibodies, and the level of degranulation was assessed as the proportion of CD107a 1 NK cells among the CD158b 1 NK cells.
METHODS
Study subjects. Ninety-one untreated subjects chronically infected with HIV-1 subtype B, for which HLA class I and KIR genotypes were available (Supplementary Table 1 ), were included in this study 9 . In addition, 100 HIV-1 negative controls were genotyped for KIR and HLA genotypes. Of this large cohort of uninfected controls, 15 subjects that were KIR2DL2 1 (KIR2DL2 1 /KIR2DL3 1 ) and 15 subjects that were KIR2DL2 2 (KIR2DL3 1 /KIR2DL3 1 ) were enrolled to provide samples for the generation of NK cells and autologous CD4 1 target cells (Supplementary Table 6 ). For these in vitro studies, only individuals that did not encode KIR3DS1 and HLA-B Bw4-80I were selected, because we had previously observed very strong inhibition of HIV-1 replication in vitro in individuals with this combined KIR/HLA genotype 6 . All study subjects were enrolled in Boston through the Massachusetts General Hospital, the Lemuel-Shattuck Hospital and the Fenway Community Health Center. The study was approved by the Massachusetts General Hospital Review Board and all subjects gave written informed consent. Viral sequencing. Genomic DNA was extracted from peripheral blood mononuclear cell samples and nested PCR protocols were used to amplify HIV-1 genomes as described previously 9 . Five independent PCR products of each sample were pooled and directly population-sequenced at the Massachusetts General Hospital DNA sequencing core facility using clade B consensus sequencing primers, as previously described 9 .
HLA class I and KIR typing. High-resolution HLA class I typing and KIR genotyping were performed as described previously 6 . Phylogenetic analysis of KIR-associated sequence polymorphisms. We used the decision-tree approach 10 , which corrects for phylogenetic structure among the sequences and allows for a multivariate analysis, to identify KIR-associated sequence polymorphisms. All results were adjusted for multiple comparisons (both P and Q values are assigned to each result). For each protein analysed, a maximum likelihood phylogenetic tree was constructed from the corresponding sequences. For every KIR and HLA gene, amino-acid position and amino acid at that position, we created two generative or directed graphical models of the observed presence or absence of the amino acid in each sequence: one representing the null hypothesis that the observations are generated by the phylogenetic tree alone and the other representing the alternative hypothesis that additional escape or reversion takes place owing to KIR/HLA pressure in the subjects for which the sequences are observed. The likelihood of the observations was then maximized over the parameters of both models using an expectation-maximization algorithm, and a P value was computed using a likelihood ratio test based on those likelihoods 10 .
To increase power, the tests were binarized, such that the presence or absence of a given KIR or HLA gene was correlated with the presence or absence of a given amino acid. In addition, KIR-polymorphism pairs were analysed only when the actual or expected count in every cell of the corresponding two-by-two contingency table was $3. For every amino acid at each position, the KIR or HLA gene with the strongest association (and its corresponding P value) was added to the list of identified associations. The analysis was then repeated after removing individuals having or possibly having this KIR or HLA gene. This procedure was iterated until no KIR or HLA gene yielded an association with a P value less than 0.05. A Q-value statistic, estimating the proportion of false positives among the associations identified, was computed for each association by repeating this analysis on null data (generated by permuting the KIR/HLA data). Correction for multiple comparisons was undertaken using both Q , 0.05 (estimating 5% false positives) and Q , 0.2 (estimating 20% false positives). Construction of viruses containing sequence polymorphisms. The HIV-1 strain NL4-3 was modified to express one or two mutations in vpu/env, nef or gag using the GeneTailor site-directed mutagenesis system (Invitrogen) or the QuikChange Lightning site-directed mutagenesis system (Stratagene) 11, 12 . In brief, mutagenesis was performed using 59 oligonucleotide primers Vpu_M71R-f (CTTGTGGAGATGGGGGTGGAAAGGGGGCACCAT (nucleotide (nt) 6279)), Vpu_M71R-r (TTTCCACCCCCATCTCCACAAGTGCTGATACTTCT (nt 6234)), Vpu_H74L-f (ATGGGGGTGGAAATGGGGCACCTTGCTCCTTGG), Vpu_H74L-r (GGTGCCCCATTTCCACCCCCATCTCCACAAG (nt 6247)), Vpu_M71R/H74L-f (ATGGGGGTGGAAAGGGGGCACCTTGCTCCTTGG (nt 6247 and nt 6288)) and Vpu_M71R/H74L-r (GGTGCCCCCTTTCCACCCCCATCTCCACAAG (nt 6247)); Nef/S9K-f (GTGGTCAAAAAGTAAAGTGATTGGATGGCC (nt 8827))
